Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis-Reference-Cited by-同舟云学术

Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis

Published:1998-11-15 Issue:10 Volume:92 Page:3495-3504
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Peters Malte¹,Müller Albrecht M.¹,Rose-John Stefan¹

Affiliation:

1. From I. Medizinische Klinik, Abteilung Pathophysiologie, Johannes Gutenberg Universität Mainz, Mainz, Germany; and Max Planck Institut für Immunbiologie, Freiburg, Germany.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference85 articles.

1. gp130 and the interleukin-6 family of cytokines.;Taga;Annu Rev Immunol,1997

2. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.;Mosley;J Biol Chem,1996

3. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.;Pennica;J Biol Chem,1995

4. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons.;Pennica;Neuron,1996

5. The biology of hematopoietic stem cells.;Morrison;Annu Rev Cell Dev Biol,1995

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-6 trans-signalling: past, present and future prospects;Nature Reviews Immunology;2023-04-17

2. Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma;Biomedicines;2022-12-12

3. Predictive Role of Soluble IL-6R, TNF-R1/2, and Cell Adhesion Molecules Serum Levels in the Preoperative and Adjuvant Therapy in Women with Nonmetastatic Breast Cancer: A Preliminary Study;Journal of Interferon & Cytokine Research;2022-11-01

4. IL-6 promotes low concentration of RANKL-induced osteoclastic differentiation by mouse BMMs through trans-signaling pathway;Journal of Molecular Histology;2022-06

5. Blocking only the bad side of IL-6 in inflammation and cancer;Cytokine;2021-12